Neutrophil extracellular traps may play role in organ failure in cancer
the ONA take:
Neutrophils may play an important role in organ failure in patients with primary or metastatic tumors, according to research out of Uppsala University published in Cancer Research.
While the main function of neutrophil blood cells is to protect against infections, the presence of tumors in the body may fool immune cells into fighting non-existent infections through the formation of neutrophil extracellular traps (NETs).
In their mouse study, the researchers demonstrated that NETs that gathered in mice with cancer caused decreased functionality of blood vessels as well as inflammation of organs that were not affected by actual or metastatic tumor cells.
DNase treatment was used to restore vascular function in the kidneys and hearts of afflicted mice to those of non-tumor-carrying mice. In addition, it also suppressed inflammation.
“Our findings strongly suggest that NETs mediate the negative collateral effects of tumors on distal organs, but that this condition is reversible,” said Anna-Karin Olsson, senior lecturer at Uppsala University.
Neutrophils may play an important role in organ failure in patients with primary or metastatic tumors.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|